FDA
label_change
· 2017-08-31
FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
Summary
The FDA approved a supplemental application for Levothyroxine Sodium from Alvogen, Inc., resulting in labeling changes for the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)